OAC
PYXS icon

OMERS Administration Corp’s Pyxis Oncology PYXS Stock Holding History

OMERS Administration Corp’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67,000
Closed -$77K – 1153
2025
Q4 		$77K Buy
+67,000
New +$236K ﹤0.01% 984
2024
Q2 		– Sell
-11,800
Closed -$50.3K – 1178
2024
Q1 		$50.3K Buy
+11,800
New +$49.6K ﹤0.01% 375

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMERS Administration Corp's PYXS Position: Q1 2026 in Review

OMERS Administration Corp sold out of Pyxis Oncology (PYXS) in Q1 2026, closing a stake of 67,000 shares — an estimated $77K sold.

OMERS Administration Corp first reported a position in PYXS in Q1 2024 and held it in 2 quarters. The position peaked at $77K in Q4 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • OMERS Administration Corp reported no remaining Pyxis Oncology position as of Q1 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 67,000 Pyxis Oncology shares in Q1 2026, an estimated $77K.
  • OMERS Administration Corp first reported a position in Pyxis Oncology in Q1 2024 and held it in 2 quarters.
  • OMERS Administration Corp's Pyxis Oncology position peaked at $77K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.